# GASTRIPEC-I (NCT02158988)

> Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: gastric cancer with synchronous peritoneal metastases

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02158988
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Charite University, Berlin, Germany
- Conditions: Malignant Neoplasm of Stomach; Secondary Malignant Neoplasm of Peritoneum; Secondary Malignant Neoplasm of Other and Unspecified Sites
- Interventions: HIPEC
- Enrollment: 105
- Primary outcome: The primary outcome measure is overall survival

## Indexed commentary on GASTRIPEC-I so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7
- YouTube: 2

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=gastripec-i-nct02158988

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02158988", "email": "<work email>"}; the inbox owner confirms by the emailed link.